Highlights
About
Clinical Decision Support Systems for Biological Therapy Recommendations
Skintelligence is the developer of clinical decision support systems (CDSSs) designed to predict an individuals response to biological therapy, specifically in the treatment of autoimmune diseases such as psoriasis, rheumatoid arthritis, and Crohns disease. The companys solution enables physicians to prescribe biological medication while avoiding the typical process of trial and error, thereby reducing both the high cost of biological treatments and the patients discomfort. Skintelligences CDSSs are based on artificial intelligence tools that enable the compilation of information fundamental to predicting a patients response to therapy. The companys patented SmartPAD (SMART Predictor for Autoimmune Diseases) comprises a device that measures immunologic biomarkers from the skin using non-invasive assays and software that integrates the biomarkers from the skin with clinical data to calculate the probability of treatment success with each of the commercial biological drugs.
Identity
| Name | Skintelligence |
|---|---|
| Slug | skintelligence |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4L745MQIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Dec 2021 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | HeHaluts Street 70, Jerusalem, Israel |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}